Header Logo

Connection

Michael Wenger to Leukemia, Lymphocytic, Chronic, B-Cell

Back to Details
This is a "connection" page, showing publications Michael Wenger has written about Leukemia, Lymphocytic, Chronic, B-Cell.
Michael Wenger
Connection Strength
0.109
Leukemia, Lymphocytic, Chronic, B-Cell
  1. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med. 2014 Mar 20; 370(12):1101-10.
    View in: PubMed
    Score: 0.109
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.